Atwood CS

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus cholinesterase inhibition to reduce neurologic decline in Alzheimer's - Butler_2021_Contemp.Clin.Trials__106488
Author(s) : Butler T , Goldberg JD , Galvin JE , Maloney T , Ravdin L , Glodzik L , de Leon MJ , Hochman T , Bowen RL , Atwood CS
Ref : Contemp Clin Trials , :106488 , 2021
Abstract : Butler_2021_Contemp.Clin.Trials__106488
ESTHER : Butler_2021_Contemp.Clin.Trials__106488
PubMedSearch : Butler_2021_Contemp.Clin.Trials__106488
PubMedID: 34166841

Title : A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks - Bowen_2015_J.Alzheimers.Dis_44_549
Author(s) : Bowen RL , Perry G , Xiong C , Smith MA , Atwood CS
Ref : J Alzheimers Dis , 44 :549 , 2015
Abstract : Bowen_2015_J.Alzheimers.Dis_44_549
ESTHER : Bowen_2015_J.Alzheimers.Dis_44_549
PubMedSearch : Bowen_2015_J.Alzheimers.Dis_44_549
PubMedID: 25310993

Title : fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: risk factors for Alzheimer's disease - Trivedi_2008_Neuropsychologia_46_1667
Author(s) : Trivedi MA , Schmitz TW , Ries ML , Hess TM , Fitzgerald ME , Atwood CS , Rowley HA , Asthana S , Sager MA , Johnson SC
Ref : Neuropsychologia , 46 :1667 , 2008
Abstract : Trivedi_2008_Neuropsychologia_46_1667
ESTHER : Trivedi_2008_Neuropsychologia_46_1667
PubMedSearch : Trivedi_2008_Neuropsychologia_46_1667
PubMedID: 18241895